Literature DB >> 17190755

Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers.

Pentti Sipponen1, David Y Graham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17190755     DOI: 10.1080/00365520600863720

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


× No keyword cloud information.
  36 in total

1.  Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.

Authors:  Massimo Rugge; Matteo Fassan; Marco Pizzi; Fabio Farinati; Giacomo Carlo Sturniolo; Mario Plebani; David Y Graham
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

Review 2.  Gastric endoscopy in the 21st century: appropriate use of an invasive procedure in the era of non-invasive testing.

Authors:  D Y Graham; M Kato; M Asaka
Journal:  Dig Liver Dis       Date:  2008-04-09       Impact factor: 4.088

Review 3.  Biomarkers for Helicobacter pylori infection and gastroduodenal diseases.

Authors:  Seiji Shiota; Yoshio Yamaoka
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

4.  Seroprevalence of Helicobacter pylori infection and gastric mucosal atrophy in Bhutan, a country with a high prevalence of gastric cancer.

Authors:  Seiji Shiota; Varocha Mahachai; Ratha-Korn Vilaichone; Thawee Ratanachu-Ek; Lotay Tshering; Tomohisa Uchida; Osamu Matsunari; Yoshio Yamaoka
Journal:  J Med Microbiol       Date:  2013-07-05       Impact factor: 2.472

Review 5.  Biomarkers of Helicobacter pylori-associated gastric cancer.

Authors:  Cara L Cooke; Javier Torres; Jay V Solnick
Journal:  Gut Microbes       Date:  2013-07-12

6.  Low Levels of Pepsinogen I and Pepsinogen I/II Ratio are Valuable Serologic Markers for Predicting Extensive Gastric Corpus Atrophy in Patients Undergoing Endoscopic Mucosectomy.

Authors:  Ho June Song; Se Jin Jang; Sung-Cheol Yun; Young Soo Park; Mi-Jung Kim; Sun-Mi Lee; Kee Don Choi; Gin Hyug Lee; Hwoon-Yong Jung; Jin-Ho Kim
Journal:  Gut Liver       Date:  2010-12-17       Impact factor: 4.519

7.  Serum glycan signatures of gastric cancer.

Authors:  Sureyya Ozcan; Donald A Barkauskas; L Renee Ruhaak; Javier Torres; Cara L Cooke; Hyun Joo An; Serenus Hua; Cynthia C Williams; Lauren M Dimapasoc; Jae Han Kim; Margarita Camorlinga-Ponce; David Rocke; Carlito B Lebrilla; Jay V Solnick
Journal:  Cancer Prev Res (Phila)       Date:  2013-12-10

8.  Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach.

Authors:  Katsunori Iijima; Yasuhiko Abe; Ryosuke Kikuchi; Tomoyuki Koike; Shuichi Ohara; Pentti Sipponen; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

9.  Serum pepsinogen II is a better diagnostic marker in gastric cancer.

Authors:  Xue-Yuan Cao; Zhi-Fang Jia; Mei-Shan Jin; Dong-Hui Cao; Fei Kong; Jian Suo; Jing Jiang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

10.  Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study.

Authors:  Huakang Tu; Liping Sun; Xiao Dong; Yuehua Gong; Qian Xu; Jingjing Jing; Qi Long; W Dana Flanders; Roberd M Bostick; Yuan Yuan
Journal:  Int J Cancer       Date:  2014-06-19       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.